Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

13.05
Real-Time Quote
As of 12:50pm ET
 +0.01 / +0.08%
Today’s Change
11.82
Today|||52-Week Range
16.00
-5.84%
Year-to-Date
Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall
Sep 14 / TheStreet.com - Paid Partner Content
Pfizer Announces Positive Late Stage Trial of Cancer Treatment
Sep 14 / TheStreet.com - Paid Partner Content
Why Did Pfizer (PFE) Stock Pop Today?
Sep 14 / Zacks.com - Paid Partner Content
Dow Hits Intraday Record but Rest of Market Falters After Inflation Reading
Sep 14 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close13.04
Today’s open13.01
Day’s range13.01 - 13.07
Volume21,216
Average volume (3 months)203,131
Market cap$26.6B
Dividend yield2.34%
Data as of 12:50pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+28.08%
Earnings growth (this year)-6.79%
Earnings growth (next 5 years)-0.42%
Revenue growth (last year)+5.93%
P/E ratio--
Price/Sales2.29
Price/Book2.36

Competitors

No competitors data available.

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.22
Annual revenue (last year)$12.1B
Annual profit (last year)$2.0B
Net profit margin16.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Representative Director
Yoshihiko Hatanaka
Chief Financial Officer
Yasumasa Masuda
Corporate headquarters
Tokyo, Tokyo

Forecasts